- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
Nephelometry has become the main method for performing protein tests, measuring the turbidity of a sample to determine the level of analyte; the difference is that immunoturbidimetric tests measure the absorbance of light by the sample whereas nephelometric tests measure the light scattered at a fixed angle.
GPP-100 Specific Protein Analyzer testing provides numerous advantages, most notably it offers lower laboratory costs, lower consumable costs, no need highly trained personnel, and are able to perform a wide range of assays.
GPP-100 is a routine clinical analysers designed for hospital, small and medium lab, clinics, thus offering test consolidation; consolidation of tests on one single platform offers improved laboratory efficiency, versatility, rapid testing and cost-savings.
Parameters :hsCRP,HbA1c,mALB,D-Dimer,ASO,RF,C3,C4 etc.can be extended to more than 30 parameters.
IFCC is a leading organization in the field of Clinical Chemistry and Laboratory Medicine worldwide.
GPP-100 is a certified Specific Protein Analyzer by IFCC.
Parameters :hsCRP,HbA1c,mALB,D-Dimer,ASO,RF,C3,C4 etc.can be extended to more than 30 parameters.
GPP-100 is a Point of Care Nephelometry Specific Protein Analyzer for measuring multiple blood tests through a single analyzer. Approved and registered by many MOH worldwide.
This is a fully automatic cartridge-based analyzer for the quantitative determination of specific proteins in the blood, serum, urine samples, including HbA1c, HS-CRP, CRP, ASO, CYS-C, RF, mALB, D-Dimer, IgM, IgG, IgA, C3, C4, etc.
Point of Care Testing (POCT) is any analytical test for human performed by a healthcare professional at the point of patient care, outside of a conventional laboratory setting. Testing this way gives fast access to test results so that clinical decisions can be made immediately.
The NHS Long Term Plan highlights the importance of patients receiving care closer to home, shifting from a traditional model of hospital-based services towards a more adaptive community-based approach. As part of the Community pharmacy contractual framework agreement 2019-2024, NHS England and Improvement committed to explore point of care testing (POCT) by community pharmacists.
Best Price Best quality
Nephelometry has become the main method for performing protein tests, measuring the turbidity of a sample to determine the level of analyte; the difference is that immunoturbidimetric tests measure the absorbance of light by the sample whereas nephelometric tests measure the light scattered at a fixed angle.
GPP-100 Specific Protein Analyzer testing provides numerous advantages, most notably it offers lower laboratory costs, lower consumable costs, no need highly trained personnel, and are able to perform a wide range of assays.
GPP-100 is a routine clinical analysers designed for hospital, small and medium lab, clinics, thus offering test consolidation; consolidation of tests on one single platform offers improved laboratory efficiency, versatility, rapid testing and cost-savings.
Parameters :hsCRP,HbA1c,mALB,D-Dimer,ASO,RF,C3,C4 etc.can be extended to more than 30 parameters.
IFCC is a leading organization in the field of Clinical Chemistry and Laboratory Medicine worldwide.
GPP-100 is a certified Specific Protein Analyzer by IFCC.
Parameters :hsCRP,HbA1c,mALB,D-Dimer,ASO,RF,C3,C4 etc.can be extended to more than 30 parameters.
GPP-100 is a Point of Care Nephelometry Specific Protein Analyzer for measuring multiple blood tests through a single analyzer. Approved and registered by many MOH worldwide.
This is a fully automatic cartridge-based analyzer for the quantitative determination of specific proteins in the blood, serum, urine samples, including HbA1c, HS-CRP, CRP, ASO, CYS-C, RF, mALB, D-Dimer, IgM, IgG, IgA, C3, C4, etc.
Point of Care Testing (POCT) is any analytical test for human performed by a healthcare professional at the point of patient care, outside of a conventional laboratory setting. Testing this way gives fast access to test results so that clinical decisions can be made immediately.
The NHS Long Term Plan highlights the importance of patients receiving care closer to home, shifting from a traditional model of hospital-based services towards a more adaptive community-based approach. As part of the Community pharmacy contractual framework agreement 2019-2024, NHS England and Improvement committed to explore point of care testing (POCT) by community pharmacists.
Best Price Best quality
We offer
